These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2999)

  • 1. The use of pluronic polyols in the precipitation of plasma proteins and its application in the preparation of plasma derivatives.
    Garcia LA; Ordonez GA
    Transfusion; 1976; 16(1):32-41. PubMed ID: 2999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal use of blood components and derivatives.
    Walter WJ; Oberman HA
    Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570
    [No Abstract]   [Full Text] [Related]  

  • 5. The separation of clotting factors II (prothrombin) and IX (plasma thromboplastin component) by isoelectric focusing.
    Pechet L; Smith JA
    Biochim Biophys Acta; 1970 Mar; 200(3):475-85. PubMed ID: 4985341
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III.
    Ruttyn Y; Brandin MP; Vijayalakshmi MA
    J Chromatogr; 1989 Jul; 491(2):299-308. PubMed ID: 2509508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new preparation of modified immune serum globulin (human) suitable for intravenous administration. I. Standardization of the reduction and alkylation reaction.
    Schroeder DD; Tankersley DL; Lundblad JL
    Vox Sang; 1981; 40(6):373-82. PubMed ID: 7293114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of hepatitis B surface antigen in commercially prepared plasma products.
    Hoofnagle JH; Gerety RJ; Thiel J; Barker LF
    J Lab Clin Med; 1976 Jul; 88(1):102-13. PubMed ID: 932529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clotting factors and platelets. Immunofluorescence evidence that fibrinogen and factor VIII are present in human washed platelets, whereas prothrombin complex factors and factor XIII are lacking.
    Betterle C; Fabris F; de Marco L; Del Prete GF; Girolami A
    Haemostasis; 1977; 6(3):171-9. PubMed ID: 328347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adsorption properties of Beidellite (author's transl)].
    Soulier JP; Prou-Wartelle O; Halle L
    Nouv Rev Fr Hematol; 1975; 15(2):183-93. PubMed ID: 241060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X and of a separate concentrate containing factor VII.
    Dike GW; Bidwell E; Rizza CR
    Br J Haematol; 1972 Apr; 22(4):469-90. PubMed ID: 4112845
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of stroma-free haemoglobin solution on the blood-clotting system in dogs.
    Uszyński L; Schier J; Rudowski W; Daszyński J
    Eur Surg Res; 1976; 8(3):204-10. PubMed ID: 947758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous human blood protein separation using immobilized metal affinity chromatography: protein C separation from prothrombin with application to the separation of factor IX and prothrombin.
    Wu H; Bruley DF
    Biotechnol Prog; 1999; 15(5):928-31. PubMed ID: 10514264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of a fraction rich in prothrombin, proconvertin, Stuart factor and antihemophilic factor B (P.P.B. fraction)].
    BLATRIX C; SOULIER JP
    Pathol Biol; 1959 Dec; 7():2477-86. PubMed ID: 13801371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.